Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line
- 1.4k Downloads
Purpose. To determine and compare the relationship between in vivo oral absorption in humans and the apparent permeability coefficients (P app ) obtained in vitro on two human intestinal epithelial cell lines, the parental Caco-2 and the TC-7 clone.
Methods. Both cell lines were grown for 5−35 days on tissue culture-treated inserts. Cell monolayers were analysed for their morphology by transmission electron micrography, and for their integrity with respect to transepithelial electrical resistance, mannitol and PEG-4000 transport, and cyclosporin efflux. Papp were determined for 20 compounds exhibiting large differences in chemical structure, molecular weight, transport mechanisms, and percentage of absorption in humans.
Results. The TC-7 clone exhibits morphological characteristics similar to those of the parental Caco-2 cell line, concerning apical brush border, microvilli, tight junctions and polarisation of the cell line. The TC-7 clone however appeared more homogenous in terms of cell size. Both cell lines achieved a similar monolayer integrity towards mannitol and PEG-4000. Monolayer integrity was achieved earlier for the TC-7 clone, mainly due to its shorter doubling time, i.e. 26 versus 30 hours for parental Caco-2 cells. When using cyclosporin A as a P-glycoprotein substrate, active efflux was lower in the TC-7 clone than in the parental Caco-2 cells. The Papp and mechanisms of transport (paracellular or transcellular routes, passive diffusion and active transport) were determined for 20 drugs. A relationship was established between the in vivo oral absorption in humans and Papp values, allowing to determine a threshold value for Pappof 2 10−6 cm/sec, above for which a 100% oral absorption could be expected in humans. Both correlation curves obtained with the two cell types, were almost completely superimposable. These studies also confirmed that the dipeptide transporter is underexpressed in both cell lines.
Conclusions. On the basis of morphological parameters, biochemical activity and drug transport characteristics, the TC-7 clone appeared to be a valuable alternative to the use of parental Caco-2 cells for drug absorption studies.
Unable to display preview. Download preview PDF.
- 1.P. Artursson. Cell culture as models for drug absorption across the intestinal mucosa. Crit. Rev. Ther. Drug Carrier System 8:105–130 (1991).Google Scholar
- 2.J. Fogh, J. M. Fogh, and T. Orfeo, 127 Cultured human colon cell lines producing tumors in nude mice. J. Natl. Acad. Sci. U.S.A. 59:221–226 (1977).Google Scholar
- 3.M. Pinto, S. Robine-Leon, M. D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh, and A. Zweibaum. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 47:323–330 (1983).Google Scholar
- 6.G. Wilson, I. F. Hassan, C. J. Dix, I. Williamson, R. Shah, M. Mackay, and P. Artursson. Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier. J. Controlled Rel. 11:25–40 (1990).Google Scholar
- 8.R. T. Borchardt, I. J. Hidalgo, K. M. Hillgren, and M. Hu. Pharmaceutical applications of cell culture: an overview. In Pharmaceutical applications of cell and tissue culture to drug transport, G. Wilson, S. S. Davis, L. Illum, and A. Zweibaum (eds.) Vol. 218, pp. 1–14, 1991 Plenum Press, New York.Google Scholar
- 11.J. N. Cogburn, M. G. Donovan, and C. S. Schasteen. Correlation of Caco-2 transport with human oral bioavailability. J. Controlled Release 13: 314–315 (1990).Google Scholar
- 16.I. Chantret, A. Rodolosse, A. Barbat, E. Dussaulx, E. Brot-Laroche, A. Zweibaum, and M. Rousset. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for a glucose-dependent negative regulation. J. Cell. Sci. 107:213–25 (1994).PubMedGoogle Scholar
- 17.L. Mahraoui, A. Rodolosse, A. Barbat, E. Dussaulx, A. Zweibaum, M. Rousset, and E. Brot-Laroche. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose transporters mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem J. (1994).Google Scholar
- 18.I. Caro, X. Boulenc, M. Rousset, V. Meunier, M. Bourrié, B. Julian, H. Joyeux, C. Roques, Y. Berger, A. Zweibaum, and G. Fabre. Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs. Int. J. Pharm. 116:147–58 (1995).Google Scholar
- 20.M. Neutra and H. Padykula. in: L. Weiss (Ed.), Histology: Cell and Tissue Biology, Elsevier, Amsterdam, pp. 658–660 (1983).Google Scholar
- 26.Clarke's Isolation and Identifying of drugs, 2nd edition. Ed. A. C. Moffat. The Pharmaceutical Press, London (1986).Google Scholar
- 28.H. Lennernäs, K. Palm, U. Fagerholm, and P. Artursson. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 127:103–107 (1996).Google Scholar
- 29.Martindale, 27th edition. Ed. A. Wade. The pharmaceutical Press, London (1977).Google Scholar
- 30.P. Nicolas, B. R. Meyers and S. Z. Hirschman. Cephalexin: Pharmacological evaluation following oral and parenteral administration. J. Clin. Pharmacol. November–December, 463–468 (1973).Google Scholar
- 31.R. J. Ptachinski, R. Venkatamaranan, and G. J. Burckart. Clinical pharmacokinetic of cyclosporin. Clin. Pharmacokin. 11:107–132 (1986).Google Scholar
- 32.A. Sandberg. Extended-release metoprolol. Doctorial Thesis, Uppsala (1994).Google Scholar
- 34.K. C. H. Yeh, T. F. August, D. F. Bush, K. C. Lasseter, D. G. Musson, S. Schwartz, M. E. Smith, and D. C. Titus. Pharmacokinetics and bioavailability of Sinemet C: a summary of human studies. Neurol. 39:25–35 (1989).Google Scholar